Timothy C. Burn

12.3k citations

91 papers · 5.8k indexed · 2 hit papers · h-index 40

Impact in

Biological Psychiatry top 1%
- Tryptophan and brain disorders
Hematology top 2%
- Acute Myeloid Leukemia Research

Papers in

Genetics 18
- Myeloproliferative Neoplasms: Diagnosis and Treatment 15
Hematology 15
- Acute Myeloid Leukemia Research 5

Co-authors: Gregory M. Landes Timothy D. Connors Terence J. Van Raay Daniel G. Tenen John M. Millholland G. Michael Vincent Jeffery A. Towbin Mark T. Keating
Journals: Blood (13 papers)Cancer Research (11 papers)Journal of Biological Chemistry (7 papers)Genomics (6 papers)Gene (5 papers)
Partner nations: United States Italy Germany

In The Last Decade

Timothy C. Burn

90 papers receiving 5.6k citations

Hit Papers

align trajectories log scale

Clinicogenomic Analysis of FGFR2 -Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib 2020 · 191 citations

Peers

Countries citing papers authored by Timothy C. Burn

Since Specialization

Citations

This map shows the geographic impact of Timothy C. Burn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy C. Burn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy C. Burn more than expected).

Fields of papers citing papers by Timothy C. Burn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy C. Burn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy C. Burn. The network helps show where Timothy C. Burn may publish in the future.

Co-authors

The 25 scholars most cited alongside Timothy C. Burn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Timothy C. Burn Line = papers co-authored together Timothy C. Burn links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	72 (PB060): TYRA-300, an oral, FGFR3-selective inhibitor: Preliminary pharmacokinetic and pharmacodynamic analysis from SURF301, the multicenter open-label phase 1/2 study of TYRA-300 in advanced urothelial carcinoma and other solid tumors with activating FGFR3 alterations European Journal of Cancer ·Chenxuan Yang, Christoph Hauptmann, Aaron R. Hansen, Charlene Mantia, Christian Meierhofer, Andrew Weickhardt, Elaine Yu, Marie Robert, E. García Re, Andrew J. Murtha, Sherry Owens, Benjamin Suttle, Gillian Vandekerkhove, Alexander W. Wyatt, Guy Gammon, Timothy C. Burn, Roven Lr	2024	0
2	Global Expanded Access Program for Pemigatinib in Patients with Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma and Fibroblast Growth Factor Receptor Gene Alterations Cancer Research and Treatment ·Moya Diaz, Gerald W. Prager, Michael Bitzer, Timothy C. Burn, Christine Lihou, Μενέλαος Χαρ. Τζιφόπουλος	2024	1
3	Validation and Characterization of FGFR2 Rearrangements in Cholangiocarcinoma with Comprehensive Genomic Profiling Journal of Molecular Diagnostics ·Ian M. Silverman, Meijuan Li, Karthikeyan Murugesan, Melanie A. Krook, Milind Javle, Robin Kate Kelley, Mitesh J. Borad, Sameek Roychowdhury, Wei Meng, Bahar Yilmazel, B. N. Satodia, 영철 주, Luis Féliz, Timothy C. Burn, Lee A. Albacker	2022	8
4	Differential expression of C5aR1 and C5aR2 in innate and adaptive immune cells located in early skin lesions of bullous pemphigoid patients Frontiers in Immunology ·Shirin Emtenani, Maike M. Holtsche, Rafaele Dalazuana Nicolotti, Daniel Seiler, Timothy C. Burn, Huiqing Liu, Clay Carter, Dean Díaz Andric, Markella Moraitou, 张西振, Christian D. Sadik, Christian M. Karsten, Nina van Beek, Ralf J. Ludwig, Jörg Köhl, Enno Schmidt	2022	7
5	Clinicogenomic Analysis of FGFR2 -Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib Cancer Discovery ·Ian M. Silverman, Antoine Hollebecque, Luc Friboulet, Sherry Owens, Robert Newton, Hui‐Ling Zhen, Luis Féliz, Camilla Zecchetto, Davide Melisi, Timothy C. Burn Hit paper breakdown →	2020	191
6	Effects of Ruxolitinib Treatment on Metabolic and Nutritional Parameters in Patients With Myelofibrosis From COMFORT-I Clinical Lymphoma Myeloma & Leukemia ·Ruben A. Mesa, Srđan Verstovšek, Vikas Gupta, John Mascarenhas, Ehab Atallah, Timothy C. Burn, William Sun, Victor Sandor, Jason Gotlib	2014	61
7	Validation of Standards for Quantitative Assessment of JAK2 c.1849G>T (p.V617F) Allele Burden Analysis in Clinical Samples Genetic Testing and Molecular Biomarkers ·Paul Collier, Keyur P. Patel, Paul Waeltz, Mark Rupar, Rajyalakshmi Luthra, Phillip C.C. Liu, Gregory Hollis, Reid Huber, Srđan Verstovšek, Timothy C. Burn	2013	7
8	Preclinical Evaluation of Local JAK1 and JAK2 Inhibition in Cutaneous Inflammation Journal of Investigative Dermatology ·Jordan S. Fridman, Peggy Scherle, Robert J. Collins, Timothy C. Burn, Brett A. Neilan, Мусаев Э.Т., Nancy Contel, Patrick J. Haley, Beth Ann Thomas, Jack Shi, Paul Collier, James D. Rodgers, Stacey Shepard, Brian Metcalf, Gregory Hollis, Robert Newton, Swamy Yeleswaram, Steven Friedman, Kris Vaddi	2011	88
9	Combined Inhibition of Janus Kinase 1/2 for the Treatment of JAK2V617F-Driven Neoplasms: Selective Effects on Mutant Cells and Improvements in Measures of Disease Severity Clinical Cancer Research ·Phillip C.C. Liu, Eian Caulder, Jun Li, Paul Waeltz, Jens Daum, Richard Wynn, Cigdem Urku, Yanlong Li, Erin L. Crowgey, Gregory Hollis, Patrick J. Haley, Richard Sparks, Andrew P. Combs, James D. Rodgers, Timothy C. Burn, Kris Vaddi, Jordan S. Fridman	2009	15
10	Abstract #2848: Small molecule inhibitors of JAK1/2 improve physiological and functional measures of cancer-associated cachexia Cancer Research ·Jordan S. Fridman, Eian Caulder, Xiaoming Wen, James D. Rodgers, Andrew P. Combs, Timothy C. Burn, Kris Vaddi	2009	1
11	Isothiazolidinone inhibitors of PTP1B containing imidazoles and imidazolines Bioorganic & Medicinal Chemistry Letters ·Brent Douty, Brian Wayland, J. Paul, Michael J. Bower, James R. Pruitt, Lori L. Bostrom, Min Wei, Ronald M. Klabe, Lucie Gonneville, Richard Wynn, Timothy C. Burn, Phillip C.C. Liu, Andrew P. Combs, Eddy W. Yue	2007	55
12	Structural Insights into the Design of Nonpeptidic Isothiazolidinone-containing Inhibitors of Protein-tyrosine Phosphatase 1B Journal of Biological Chemistry ·J. Paul, Lucie Gonneville, Milton C. Hillman, Cigdem Urku, Eddy W. Yue, Brent Douty, Brian Wayland, Padmaja Polam, Matthew L. Crawley, Erin McLaughlin, Richard Sparks, Brian Glass, Amy Takvorian, Andrew P. Combs, Timothy C. Burn, Gregory Hollis, Richard Wynn	2006	55
13	Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4) Matrix Biology ·Micky D. Tortorella, Rui‐Qin Liu, Timothy C. Burn, Robert Newton, Elizabeth C. Arner	2002	119
14	Ligand and coactivator recruitment preferences of peroxisome proliferator activated receptor α The Journal of Steroid Biochemistry and Molecular Biology ·Ranjan Mukherjee, Shaoxian Sun, Linda D. Santomenna, Bowman Miao, Harry L. Walton, Neeldipsinh Jadeja, Цветелина Горинова, Ji-Hu Zhang, 张慧玲, Susanne de Jong, Kathleen Murphy, Cláudia Batista, Menghang Xia, Christopher A. Teleha, Nazlı Hazal Işık, Bernard Selling, Richard Wynn, Timothy C. Burn, Peter R. Young	2002	36
15	Sites of Aggrecan Cleavage by Recombinant Human Aggrecanase-1 (ADAMTS-4) Journal of Biological Chemistry ·Micky D. Tortorella, Michael A. Pratta, Rui‐Qin Liu, 裕士小野田, O.Harold Ross, Ilgar Abbaszade, Timothy C. Burn, Elizabeth C. Arner	2000	192
16	Multiple control elements are required for expression of the human CD34 gene Gene ·Hanna S. Radomska, Anne B. Satterthwaite, Timothy C. Burn, Ira A. Oliff, Daniel G. Tenen	1998	26
17	Practicing managed care in the academic medical center. PubMed ·Timothy C. Burn	1996	1
18	Generation of a transcriptional map for a 700-kb region surrounding the polycystic kidney disease type 1 (PKD1) and tuberous sclerosis type 2 (TSC2) disease genes on human chromosome 16p3.3. Genome Research ·Timothy C. Burn, Timothy D. Connors, Terence J. Van Raay, William R. Dackowski, John M. Millholland, K. Klinger, Gregory M. Landes	1996	20
19	Increased exon-trapping efficiency through modifications to the pSPL3 splicing vector Gene ·Timothy C. Burn, Timothy D. Connors, K. Klinger, Gregory M. Landes	1995	52
20	Optimization of transient transfection into human myeloid cell lines using a luciferase reporter gene. PubMed ·Heike L. Pahl, Timothy C. Burn, Daniel G. Tenen	1991	95

About Timothy C. Burn

Timothy C. Burn is a scholar working on Genetics, Hematology, Molecular Biology, Biological Psychiatry and Oncology, having authored 91 papers that have together received 5.8k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers), Fibroblast Growth Factor Research (11 papers), Cytokine Signaling Pathways and Interactions (9 papers), Epigenetics and DNA Methylation (8 papers), Kruppel-like factors research (7 papers), Acute Myeloid Leukemia Research (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Protein Tyrosine Phosphatases (5 papers). The work is most often cited by research in Biological Psychiatry (311 citations), Hematology (622 citations), Genetics (576 citations), Cardiology and Cardiovascular Medicine (1.2k citations) and Molecular Biology (3.5k citations). Timothy C. Burn has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Gregory M. Landes, Timothy D. Connors, Terence J. Van Raay, Daniel G. Tenen, John M. Millholland, G. Michael Vincent, Jeffery A. Towbin, Mark T. Keating, Arthur J. Moss and Donald L. Atkinson. Their work appears in journals such as Blood, Cancer Research, Journal of Biological Chemistry, Genomics and Gene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact